The days of simply manufacturing a device, and selling it to healthcare providers via distributors, have long vanished. Value is the new byword for success, prevention the preferred clinical outcome, and intelligence the new competitive advantage. This paper examines the pathway to success in 2030 for medical device organizations.
CMS issued a proposed rule for the Medicare Advantage and Part D programs that implements specific requirements in the Comprehensive Addiction and Recovery Act (CARA) and the 21st Century Cures Act (Cures).
Healthcare and life sciences will face continued disruption in 2018 as new technologies emerge, economic pressures continue and consumer/patient demands evolve. KPMG and Leavitt Partners surveyed 265 corporate finance professionals about their thoughts about the industry and 12 separate sub-sectors.
The Centers for Medicare and Medicaid Services published a final rule with comment period on policies and requirements for physicians and other clinicians participating in the second year of the Quality Payment Program effective January 2018.
This paper explores the implications of the U.S. Department of Health and Human Services (HHS) proposed rule for the 2019 Marketplaces updates on various annual individual and small group market insurance product parameters.